Mark S Shearman Insider Trading $AGTC APPLIED GENETIC TECHNOLOGIES CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark S Shearman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark S Shearman. Mark S Shearman is Chief Scientific Officer in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and EVP, Chief Scientific Officer in Editas Medicine, Inc. ($EDIT).
Mark S Shearman in APPLIED GENETIC TECHNOLOGIES CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark S Shearman: Chief Scientific Officer
Holdings: 33,277 shares
Current Value: $214,637
Latest Transaction: Aug 18 2020
$AGTC Market Capitalization: $115.53M
$AGTC Previous Close: $6.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark S Shearman in APPLIED GENETIC TECHNOLOGIES CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18 2020 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Payment of Exercise | F | 5.77 | 5,723 | 33,022 | 33,277 | 39 K to 33.3 K (-14.67 %) |
| Aug 07 2020 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 5.50 | 50,000 | 275,000 | 50,000 | |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 3.00 | 52,000 | 156,000 | 52,000 | |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Grant | A | 0.00 | 39,000 | 0 | 39,000 | 0 to 39 K |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Sell | S | 3.35 | 3,000 | 10,053 | 0 | 3 K to 0 (-100.00 %) |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 4.25 | 85,000 | 361,250 | 85,000 | |
| Jul 18 2017 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 4.90 | 50,000 | 245,000 | 50,000 | |
| Sep 26 2016 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Buy | P | 8.87 | 1,300 | 11,531 | 3,000 | 1.7 K to 3 K (+76.47 %) |
| Sep 26 2016 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Buy | P | 8.87 | 1,700 | 15,071 | 1,700 | 0 to 1.7 K |
| Jul 11 2016 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 15.57 | 50,000 | 778,500 | 50,000 | |
| Jul 23 2015 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 18.48 | 51,000 | 942,480 | 51,000 | |
| Jun 02 2015 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 19.50 | 110,000 | 2,145,000 | 110,000 |
Page: 1